P Valent
Overview
Explore the profile of P Valent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
315
Citations
5810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nachtkamp K, Strupp C, Vukelja M, Kasprzak A, Haase D, Ganster C, et al.
Leukemia
. 2024 Jan;
38(2):442-445.
PMID: 38263435
No abstract available.
2.
Zeilinger E, Oppenauer C, Knefel M, Kantor V, Schneckenreiter C, Lubowitzki S, et al.
Epidemiol Psychiatr Sci
. 2022 Oct;
31:e74.
PMID: 36245424
Aims: Cancer patients often present with psychological symptoms that affect their quality of life, physical health outcomes and survival. Two of the most frequent psychiatric comorbidities are anxiety and depression....
3.
van der Kouwe E, Heller G, Czibere A, Pulikkan J, Agreiter C, Castilla L, et al.
Blood
. 2021 May;
138(15):1345-1358.
PMID: 34010414
The blood system serves as a key model for cell differentiation and cancer. It is orchestrated by precise spatiotemporal expression of crucial transcription factors. One of the key master regulators...
4.
Fureder W, Sperr W, Heibl S, Zebisch A, Pfeilstocker M, Stefanzl G, et al.
Ann Hematol
. 2020 Aug;
99(10):2303-2313.
PMID: 32856141
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disease characterized by a deregulated complement system, chronic Coombs-negative, intravascular hemolysis, and a variable clinical course with substantial risk to develop thromboembolic...
5.
Kuendgen A, Nomdedeu M, Tuechler H, Garcia-Manero G, Komrokji R, Sekeres M, et al.
Leukemia
. 2020 Jun;
35(3):835-849.
PMID: 32595214
In the current World Health Organization (WHO)-classification, therapy-related myelodysplastic syndromes (t-MDS) are categorized together with therapy-related acute myeloid leukemia (AML) and t-myelodysplastic/myeloproliferative neoplasms into one subgroup independent of morphologic or...
6.
Najafi N, Hofer G, Gattinger P, Smiljkovic D, Blatt K, Selb R, et al.
Sci Rep
. 2019 Mar;
9(1):4006.
PMID: 30850635
The cross-linking of effector cell-bound IgE antibodies by allergens induces the release of inflammatory mediators which are responsible for the symptoms of allergy. We demonstrate that a recombinant hybrid molecule...
7.
Kaivers J, Lauseker M, Hildebrandt B, Fenaux P, Pfeilstocker M, Valent P, et al.
Leuk Res
. 2018 Aug;
72:27-33.
PMID: 30075323
The IPSS-R proved to be a powerful tool for the assessment of prognosis in MDS patients. We aimed at a validation of the IPSS-R for patients with MDS harboring deletion...
8.
Gadermaier E, Marth K, Lupinek C, Campana R, Hofer G, Blatt K, et al.
Allergy
. 2018 Jan;
73(7):1425-1435.
PMID: 29315611
Background: Recombinant hypoallergenic allergen derivatives have been used in clinical immunotherapy studies, and clinical efficacy seems to be related to the induction of blocking IgG antibodies recognizing the wild-type allergens....
9.
Peter B, BiBi S, Eisenwort G, Wingelhofer B, Berger D, Stefanzl G, et al.
Leukemia
. 2017 Dec;
32(4):1016-1022.
PMID: 29249817
Systemic mastocytosis (SM) is a mast cell (MC) neoplasm with complex pathology and a variable clinical course. In aggressive SM (ASM) and MC leukemia (MCL), responses to conventional drugs are...
10.
Eckl-Dorna J, Froschl R, Lupinek C, Kiss R, Gattinger P, Marth K, et al.
Allergy
. 2017 Oct;
73(5):1003-1012.
PMID: 29083477
Background: Administration of the therapeutic anti-IgE antibody omalizumab to patients induces strong increases in IgE antibody levels. Objective: To investigate the effect of intranasal administration of major birch pollen allergen...